In a patient with esophageal perforation confirmed on computed tomography (CT), does oesophagogastroduodenoscopy (OGD) have any diagnostic or therapeutic role?

Role of OGD in CT-Confirmed Esophageal Perforation

In patients with esophageal perforation already confirmed on CT, diagnostic OGD has a limited role and should be avoided as a routine first-line exam due to risks of enlarging the perforation and worsening contamination; however, OGD has a critical therapeutic role when endoscopic closure is planned for stable patients meeting specific criteria. 1

Diagnostic Role: Limited and Selective

When Diagnostic OGD May Be Considered

• Doubtful CT findings only: Diagnostic endoscopy is useful when CT findings are equivocal or uncertain 1
• Already confirmed perforation: Once CT has confirmed the perforation, diagnostic endoscopy adds little value and carries significant risk 1

Key Risks to Consider

The primary concern with diagnostic OGD in confirmed perforation is:

• Enlarging the perforation size
• Aggravating contamination of mediastinal and pleural spaces
• These risks warrant extreme caution and limit its use as a first-line diagnostic exam 1

Therapeutic Role: Gold Standard in Select Cases

When Therapeutic OGD is Indicated

Immediate endoscopic closure is the gold standard when perforation occurs and is recognized during an endoscopic procedure 1

For perforations confirmed on CT, endoscopic treatment should be considered for:

Ideal Candidates for Endoscopic Management:

• Hemodynamically stable patients 2
• Early presentation (ideally within 24 hours) 1
• Contained esophageal disruption with minimal contamination 1
• Small perforations (< 2 cm are ideal for clip closure) 1
• Absence of peritoneal signs or frank peritonitis 2

Available Endoscopic Techniques:

1. Through-the-scope clips (TTSC) or over-the-scope clips (OTSC): Standard for small (< 2 cm) perforations 1
2. Self-expanding metal stents (SEMS): For larger defects or when clip closure is unsatisfactory 1
   • Success rate: 88% with 7.5% mortality (comparable to surgery at 83% success, 17% mortality) 1
   • Requires 2-4 weeks minimum placement duration 1
3. Endoscopic suturing: For defect reinforcement 2
4. Endoluminal vacuum therapy: Emerging promising alternative 1

Critical Decision Algorithm

Step 1: Patient Stability Assessment

• Unstable patients (hemodynamic instability, severe sepsis, frank peritonitis) → Emergency surgery without endoscopic attempt 2, 1
• Stable patients → Proceed to Step 2

Step 2: Timing and Contamination Assessment

• Early presentation (< 24 hours) + contained perforation + minimal contamination → Consider endoscopic therapy 1
• Delayed presentation (> 24 hours) + extensive contamination + mediastinitis → Surgery preferred 1

Step 3: Perforation Characteristics

• Small defect (< 2 cm) → Endoscopic clips 1
• Larger defect → SEMS or combination therapy 1
• Very large disruption or preexistent esophageal disease → Surgery 1

Common Pitfalls to Avoid

1. Never perform diagnostic OGD in unstable patients - these patients need immediate surgery 2
2. Don't delay treatment for endoscopy - mortality increases significantly with delays beyond 24 hours 3, 4
3. Avoid endoscopic attempts in frank peritonitis - surgical management is mandatory 2
4. Don't use endoscopy as first-line diagnostic tool when CT has already confirmed perforation - the risks outweigh benefits 1

Practical Approach

For a patient with CT-confirmed esophageal perforation:

• If stable + early + contained → Proceed directly to therapeutic OGD with appropriate closure devices ready
• If unstable or delayed or extensive contamination → Surgery without endoscopic intervention
• If CT findings uncertain despite suspicion → Diagnostic OGD may clarify, but use extreme caution 1

The key distinction is that OGD's role shifts from diagnostic (minimal value when CT already confirms perforation) to therapeutic (potentially definitive treatment in properly selected patients). Endoscopic management can be as effective as surgery (88% vs 83% success) with lower mortality (7.5% vs 17%) in appropriately selected stable patients with contained perforations 1.